A private drug company has developed an experimental cancer drug that has produced apparently “extraordinary” results، with a third of very ill lymphoma patients showing no signs of the disease after a single treatment. Reported independent. However the company، Kite Pharma، cautioned that its version of CAT-T cell therapy may have also killed two of the 101 people in the study. The patients had non-Hodgkin lymphoma and all other treatments had failed. Normally they could expect to live for about six months. Nearly nine months later، more than a third showed no sign of the disease and more than half were still alive.